Effects of dietary fatty acids on DU145 human prostate cancer cell growth in athymic nude mice

被引:69
|
作者
Connolly, JM [1 ]
Coleman, M [1 ]
Rose, DP [1 ]
机构
[1] Amer Hlth Fdn, Div Nutr & Endocrinol, Valhalla, NY 10595 USA
来源
关键词
D O I
10.1080/01635589709514611
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study was to examine the effects of diets containing different unsaturated fatty acids (FAs) on DU145 human prostate cancer cell growth in nude mice. In Experiment 1, groups of 25 mice were fed 23% (wt/wt) fat diets containing 18% corn oil (CO)-5% linseed oil (18:2n-6 FA-rich), 18% linseed oil (LO)-5% CO (18:3n-3 FA-rich), or 18% menhaden oil (MO)-5% CO (20:5 and 22:6n-3 FA-rich), and seven days later they were injected subcutaneously with 1 x 10(6) DU145 cells. The diets were continued for six weeks. The growth rates and final weights of tumors from the 18% CO-5% LO and 18% LO-5% CO mice were similar; there was a 30% reduction in tumor growth in the 18% MO-5% CO group (p < 0.001). The tumor phospholipid FA patterns suggested that the inhibitory effect of the high-MO diet was due, at least in part, to a reduction of arachidonic acid available for prostaglandin biosynthesis. In Experiment 2, groups of 25 mice were injected with 5 x 10(5) or 1 x 10(6) DU145 cells directly into the prostate gland and fed a high-fat linoleic acid (n-6 FA)-rich or a low-fat diet for 10 weeks. At necropsy macroscopic cancers and microscopic intraprostatic tumors were evaluated. When the initial tamer load was 1 x 10(6) cells, all but 7 of the 50 mice had developed large macroscopic tumors; the mean tumor weight in the high-fat group was twice that in the low-fat group (p = 0.047). A stimulatory effect of dietary n-6 FA on DU145 prostate cancer cell growth may require a critical initial tumor cell mass.
引用
收藏
页码:114 / 119
页数:6
相关论文
共 50 条
  • [1] Efficacy of suramin against human prostate carcinoma DU145 xenografts in nude mice
    Church, D
    Zhang, YL
    Rago, R
    Wilding, G
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (03) : 198 - 204
  • [2] Efficacy of suramin against human prostate carcinoma DU145 xenografts in nude mice
    Dawn Church
    Yunlei Zhang
    Randall Rago
    George Wilding
    Cancer Chemotherapy and Pharmacology, 1999, 43 : 198 - 204
  • [3] Differential effects of fatty acids on PC3 and DU145 prostate cancer cells
    Switzer, BR
    Goodell, P
    Thomas, N
    Gitzinger, FM
    Vollmer, R
    Demark-Wahnefried, W
    FASEB JOURNAL, 2004, 18 (05): : A766 - A766
  • [4] Scanning electron microscope characteristics of human prostate adenocarcinoma cell line (DU145) transplanted in nude mice
    Gilloteaux, J
    Jamison, JM
    Arnold, D
    Summers, JL
    SCANNING, 1999, 21 (02) : 106 - 107
  • [5] Induction of cell cycle arrest in DU145 human prostate cancer cells by the dietary compound piceatannol
    Lee, Yeo Myeong
    Cho, Han Jin
    Lim, Do Young
    Kim, Jin Kyung
    Park, Jung Han Yoon
    FASEB JOURNAL, 2008, 22
  • [6] Stable lower PAR expression decreased DU145 prostate cancer cell growth in SCID mice
    Platica, M
    Ivan, E
    Chen, S
    Holland, JF
    Gil, J
    Mandeli, J
    Platica, O
    PROSTATE, 2001, 49 (03): : 200 - 207
  • [7] EFFECTS OF DIETARY MENHADEN OIL AND RETINYL ACETATE ON THE GROWTH OF DU-145 HUMAN PROSTATIC ADENOCARCINOMA CELLS TRANSPLANTED INTO ATHYMIC NUDE-MICE
    ROSE, DP
    COHEN, LA
    CARCINOGENESIS, 1988, 9 (04) : 603 - 605
  • [8] Induction of cell cycle arrest in DU145 human prostate cancer cells by the dietary compound isoliquiritigenin (ISL)
    Lee, Yeomyeong
    Choi, Hyun Ju
    Jung, Jae In
    Park, Jung H. Y.
    FASEB JOURNAL, 2007, 21 (05): : A360 - A360
  • [9] Morphological and biological characterization of selected DU145 human prostate cancer cell subpopulations
    Chunthapong, J
    Lubaroff, DM
    Hendrix, MJC
    Heidger, PM
    FASEB JOURNAL, 2004, 18 (04): : A416 - A416
  • [10] Bufalin combined with hydroxycamptothecin affect in vitro cell growth and apoptosis of human Du145 prostate cancer cells
    Zhang, Qingchuan
    Gu, Renze
    Niu, Tianli
    Chen, Yufeng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (06): : 11037 - 11043